Abstract
The susceptibility of 2,426 gram-negative bacteria obtained from 18 Spanish hospitals to ciprofloxacin was evaluated. Among different medical centers, susceptibility to ciprofloxacin ranged from 83 to 100 % forEnterobacteriaceae, from 35 to 100 % forPseudomonas aeruginosa, from 0 to 100 % forXanthomonas maltophilia, Acinetobacter spp. and other gram-negative non-fermenting bacilli, and from 33 to 100 % forCampylobacter spp. All clinical isolates ofHaemophilus influenzae, Moraxella catarrhalis andNeisseria gonorrhoeae were susceptible to ciprofloxacin.
Similar content being viewed by others
References
Wolfson JS, Hooper DC: Fluoroquinolone antimicrobial agents. Clinical Microbiology Reviews 1989, 2: 378–424.
Satta G, Siddu D, Cornaglia G, Pruna M: Ciprofloxacin and resistance to antibiotics in gram-positive and gramnegative bacteria. Reviews of Infectious Diseases 1988, 10, Supplement 1: 65–66.
Chin NX, Clynes N, Neu HC: Resistance to ciprofloxacin appearing during therapy. American Journal of Medicine 1989, 87, Supplement 5A: 28–31.
Wiedemann B, Zuhlsdorf MT: Brief report: resistance development to fluoroquinolones in Europe. American Journal of Medicine 1989, 87, Supplement 5A: 9–11.
Barry AL, Fuchs PC, Pfaller MA, Allen SD, Gerlach EH: Prevalence of fluoroquinolone-resistant bacterial isolates in four medical centers during the first quarter of 1990. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 906–908.
Femandes FJ, Ackerman VP: In vitro studies of ciprofloxacin and survey of resistance patterns in current isolates. Diagnostic Microbiology and Infectious Disease 1990, 13: 79–90.
López-Brea M, Alarcón T: Isolation of fluoroquinolone-resistantEscherichia coli andKlebsiella pneumoniae from an infected Hickman catheter. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 345–347.
Kresken M, Jansen A, Wiedemann B: Prevalence of resistance of aerobic gram-negative bacilli to broad-spectrum antibacterial agents: results of a multicenter study. Journal of Antimicrobial Chemotherapy 1990, 25: 1022–1024.
Chamberland S, Malouin F, Rabin HR, Schollaardt T, Parr TR, Bryan LE: Persistence ofPseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency. Journal of Antimicrobial Chemotherapy 1990, 25: 995–1010.
Ball P: Emergent resistance to ciprofloxacin amongstPseudomonas aeruginosa andStaphylococcus aureus: clinical significance and therapeutic approaches. Journal of Antimicrobial Chemotherapy 1990, 26, Supplement F: 165–179.
Gootz TD, Martin BA: Characterization of high-level quinolone resistance inCampylobacter jejuni. Antimicrobial Agents and Chemotherapy 1991, 35: 840–845.
Aguiar JM, Chacón J, Cantón R, Baquero F: The emergence of highly fluoroquinolone-resistantEscherichia coli in community-acquired urinary tract infections. Journal of Antimicrobial Chemotherapy 1992, 29: 349–350.
National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A2. NCCLS, Villanova, PA, 1990.
García-Rodríguez JA, García Sánchez JE, García García MI, García Sánchez E, Muñoz Bellido JL: In vitro activities of new oral β-lactams and macrolides againstCampy-lobacter pylori. Antimicrobial Agents and Chemotherapy 1989, 33: 1650–1651.
Wolfson JS, Hooper DC: Bacterial resistance to quinolones: mechanisms and clinical importance. Reviews of Infectious Diseases 1989, 11, Supplement 5: 960–968.
Author information
Authors and Affiliations
Consortia
Additional information
Spanish Study Group on Quinolone Resistance: J.A. García-Rodríguez, J.E. García-Sánchez, E. García-Sánchez, I. Trujillano, M.I. García García, M.J. Fresnadillo (Salamanca); F. Baquero, J. Martínez Beltrán, E. Bouza, M. Rodríguez, M. López Brea, J.J. Picazo, F. Soriano (Madrid); E. Perea (Sevilla); M. de la Rosa, G. Piédrola (Granada); F. Martín Luengo (Murcia); J. García de Lomas, M. Gobernado (Valencia); R. Martín, G. Prats (Barcelona); R. Gómez Lus, M.L. Aisa (Zaragoza); R. Cisterna (Vizcaya); C. García Riestra (Santiago de Compostela).
Rights and permissions
About this article
Cite this article
García-Rodríguez, J.A., Fresnadillo, M.J., García García, M.I. et al. Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 14, 456–459 (1995). https://doi.org/10.1007/BF02114906
Issue Date:
DOI: https://doi.org/10.1007/BF02114906